Immuneering Corp. (IMRX)
4.61
-0.17
(-3.56%)
USD |
NASDAQ |
Sep 09, 14:39
Immuneering Price : 4.61 for Sept. 9, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 08, 2026 | 4.82 | 4.885 | 4.685 | 4.78 | 1.044M |
| Sep 04, 2026 | 4.94 | 5.00 | 4.805 | 4.82 | 1.000M |
| Sep 03, 2026 | 5.085 | 5.105 | 4.93 | 5.04 | 424432.0 |
| Sep 02, 2026 | 4.85 | 5.055 | 4.80 | 5.02 | 678701.0 |
| Sep 01, 2026 | 4.90 | 4.985 | 4.84 | 4.85 | 435184.0 |
| Aug 31, 2026 | 5.00 | 5.01 | 4.862 | 4.99 | 587881.0 |
| Aug 28, 2026 | 5.21 | 5.214 | 4.935 | 4.99 | 793869.0 |
| Aug 27, 2026 | 5.19 | 5.395 | 5.12 | 5.21 | 788389.0 |
| Aug 26, 2026 | 5.23 | 5.23 | 5.109 | 5.15 | 461152.0 |
| Aug 25, 2026 | 5.20 | 5.38 | 5.20 | 5.23 | 364301.0 |
| Aug 24, 2026 | 5.31 | 5.35 | 5.125 | 5.18 | 400571.0 |
| Aug 21, 2026 | 5.31 | 5.43 | 5.281 | 5.30 | 445715.0 |
| Aug 20, 2026 | 5.25 | 5.37 | 5.20 | 5.25 | 473164.0 |
| Aug 19, 2026 | 5.18 | 5.37 | 5.14 | 5.33 | 751062.0 |
| Aug 18, 2026 | 5.14 | 5.20 | 4.96 | 5.03 | 512524.0 |
| Aug 17, 2026 | 5.00 | 5.27 | 4.99 | 5.22 | 486885.0 |
| Aug 14, 2026 | 5.18 | 5.18 | 4.93 | 5.06 | 524220.0 |
| Aug 13, 2026 | 5.06 | 5.26 | 5.06 | 5.20 | 1.084M |
| Aug 12, 2026 | 4.82 | 5.095 | 4.73 | 5.07 | 902995.0 |
| Aug 11, 2026 | 4.55 | 4.865 | 4.55 | 4.80 | 1.065M |
| Aug 10, 2026 | 4.52 | 4.65 | 4.51 | 4.53 | 706836.0 |
| Aug 07, 2026 | 4.53 | 4.57 | 4.430 | 4.51 | 723266.0 |
| Aug 06, 2026 | 4.64 | 4.72 | 4.350 | 4.46 | 772324.0 |
| Aug 05, 2026 | 4.46 | 4.485 | 4.318 | 4.39 | 508605.0 |
| Aug 04, 2026 | 4.22 | 4.41 | 4.20 | 4.40 | 764821.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Regeneron Pharmaceuticals, Inc. | 803.49 |
| ACADIA Pharmaceuticals, Inc. | 27.85 |
| Alnylam Pharmaceuticals, Inc. | 254.27 |
| Anika Therapeutics, Inc. | 21.00 |
| Savara, Inc. | 5.405 |
Price Related Metrics
| Price to Book Value | 1.564 |
| Earnings Yield | -22.38% |
| Market Cap | 298.26M |